ISSN: 1859 - 2872
Invasive aspergillosis after liver transplantation: A rare case of multisystem involvement and successful treatment
Main Article Content
Tóm tắt
Background: Aspergillosis is a rare but severe opportunistic fungal infection in liver transplant patients. Early and definitive diagnosis is crucial for selecting antifungal therapy and adjusting immunosuppressive regimens to improve patient outcomes. Case report: A 46-year-old male, three months post-liver transplant, was hospitalized with fever, neutropenia, left hemiparesis, leg pain, and skin lesions. CT angiography revealed partial femoral and calf artery occlusion, while brain MRI suggested invasive fungal infection. Skin biopsy confirmed Aspergillus infection. The patient was treated with voriconazole and tacrolimus, leading to significant improvement. After one month of antifungal therapy, he achieved stable liver function and was discharged. This case highlighted the importance of early diagnosis and appropriate treatment in managing Aspergillus infections.
Article Details
Các tài liệu tham khảo
2. Liu X, Ling Z, Li L, Ruan B (2011) Invasive fungal infections in liver transplantation. International Journal of Infectious Diseases 15(5): 298-304. doi:https://doi.org/10.1016/j.ijid.2011.01.005
3. Husain S, Camargo JF (2019) Invasive Aspergillosis in solid-organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33(9): 13544. doi:10.1111/ctr.13544
4. Donnelly JP, Chen SC, Kauffman CA et al (2019) Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clinical Infectious Diseases 71(6): 1367-1376. doi:10.1093/cid/ciz1008
5. Patterson TF, Thompson GR, 3rd, Denning DW, et al (2016) Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 63(4): 1-60. doi:10.1093/cid/ciw326
6. Gustot T, Maillart E, Bocci M et al (2014) Invasive aspergillosis in patients with severe alcoholic hepatitis. J Hepatol 60(2): 267-274. doi: 10.1016/j.jhep.2013.09.011
7. Saliba F, Delvart V, Ichaï P et al (2013) Fungal infections after liver transplantation: Outcomes and risk factors revisited in the MELD era. Clin Transplant 27(4): 454-461. doi:10.1111/ctr.12129.
8. Neofytos D, Shoham S, Dierberg K et al (2012) Diagnostic and therapeutic challenges in a liver transplant recipient with central nervous system invasive aspergillosis. Diagn Microbiol Infect Dis 73(4): 374-275. doi: 10.1016/j.diagmicrobio.2012.05.001
9. Giannella M, Bartoletti M, Morelli M et al (2016) Antifungal prophylaxis in liver transplant recipients: one size does not fit all. Transpl Infect Dis 18(4): 538-44. doi:10.1111/tid.12560
10. Iemmolo RM, Rossanese A, Rotilio A et al (1998) Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery. J Hepatol 28(3): 518-522. doi:10.1016/s0168-8278(98)80329-2
11. Nivoix Y, Velten M, Letscher-Bru V et al (2008 Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 47(9): 1176-1184. doi:10.1086/592255
Article Sidebar
